FDA Approved: PENTOBARBITAL SODIUM — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved an Original Application (ANDA) for pentobarbital sodium from Sagent Pharmaceuticals, establishing a generic version of this barbiturate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Insomnia

Drugs mentioned

• Pentobarbital sodium (Pentobarbital sodium)

Snippet

ORIG AP for PENTOBARBITAL SODIUM (PENTOBARBITAL SODIUM)